文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

自适应磁共振引导外照射放疗用于复发性宫颈癌巩固治疗

Adaptive Magnetic Resonance-Guided External Beam Radiation Therapy for Consolidation in Recurrent Cervical Cancer.
PubMed 文献 · Adv Radiat Oncol · 2022-06-26

本文报告一例31岁宫颈癌患者,初治行宫颈切除术,复发后接受同步放化疗及近距离放疗 boost,因复发灶与左子宫动脉位置关系致间质导管置入受阻、靶区覆盖不足,遂采用自适应磁共振引导外照射放疗(aMRgRT)作为 boost 以达到剂量学目标。作者认为在近距离放疗不可行的情况下,aMRgRT 可能是令人满意的替代方案,但近距离放疗仍是局部晚期宫颈癌 boost 的标准治疗。

要点

  • 一例31岁宫颈癌患者初治行宫颈切除术,后出现宫旁复发。
  • 复发灶因与左子宫动脉位置关系致间质导管置入受阻,近距离放疗 boost 覆盖不足。
  • 采用 aMRgRT 作为 boost 以达到剂量学目标,作者认为近距离放疗仍为标准治疗。

核心结论

  • 在近距离放疗不可行的情况下,aMRgRT 可能是令人满意的替代方案,但近距离放疗仍是局部晚期宫颈癌 boost 的标准治疗。

研究设计与样本

  • 本文为个案报告,报告一例31岁宫颈癌患者宫旁复发病例。

主要发现

  • 患者初治行宫颈切除术,复发后接受同步放化疗及近距离放疗 boost。
  • 因复发灶与左子宫动脉位置关系致间质导管置入受阻,近距离放疗覆盖不足。
  • 采用 aMRgRT 作为 boost 以达到剂量学目标,作者认为在近距离放疗步骤受阻时 aMRgRT 具有多项优势。
  • 每日原生 MR 成像在盆腔优于常规 X 线成像,可优化重新定位。
  • aMRgRT 的特定工作流程允许实施自适应治疗,考虑危及器官和靶区的分次间及分次内运动。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Adaptive magnetic resonance (MR)-guided brachytherapy takes an important place as consolidation within the care of cervical malignancies, but may be impracticable in some unusual cases. This work aimed to present the case of adaptive MR-guided external beam radiation therapy (aMRgRT) used as a boost in a recurrence of cervical cancer. METHODS AND MATERIALS: We report on a case of a parametrial recurrence in a 31-year-old patient who already underwent a trachelectomy as treatment for her primary growth. After concomitant radio-chemotherapy, a brachytherapy boost was performed. Because of its position in relation to the left uterine artery after trachelectomy, impeding interstitial catheters set up, the relapse was insufficiently covered. With the aim to refine the coverage of target volumes, aMRgRT treatment was undertaken to allow for achievement of the dosimetric goals. RESULTS: In clinical circumstances where the brachytherapy step was hindered, aMRgRT presents many advantages. First, daily native MR-imaging outperforms usual x-ray imaging in the pelvis, refining repositioning. Second, its specific workflow allows for the performance of adaptive treatment, with consideration of both the inter- and intrafraction motions of organs at risk and target volumes. CONCLUSION: In nonfeasible brachytherapy situations, aMRgRT could be a satisfying substitute. Nevertheless, brachytherapy remains the standard of care as a boost in locally advanced cervical cancer.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Felici F, Benkreira M, Lambaudie É, et al. Adaptive Magnetic Resonance-Guided External Beam Radiation Therapy for Consolidation in Recurrent Cervical Cancer. Adv Radiat Oncol. 2022. PMID: 36060635. doi:10.1016/j.adro.2022.100999

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。